SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001615219-22-000144
Filing Date
2022-11-08
Accepted
2022-11-08 17:42:33
Documents
1
Period of Report
2022-11-03

Document Format Files

Seq Description Document Type Size
1 FORM 4/A wf-form4a_166794733755240.html 4/A  
1 FORM 4/A wf-form4a_166794733755240.xml 4/A 4917
  Complete submission text file 0001615219-22-000144.txt   6406
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Issuer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2450 HOLCOME BLVD. SUITE J-608 HOUSTON TX 77021
Business Address
Arthur David J. (Reporting) CIK: 0001769331 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36812 | Film No.: 221370131